Details of the Drug
General Information of Drug (ID: DM17GMN)
| Drug Name | 
                     EG-011 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        Ad-VEGF D; Trinam-variants (refractory angina), Ark Therpeutics Group; Adenoviral short-form VEGF D gene therapy (angina/peripheral vascular disease), Ark Therapeutics; Short form VEGF-D gene therapy (refractory angina/peripheral vascular disease), Ark Therapeutics Group
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References

